Publication | Closed Access

Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer

Pancreatic CancerGastrointestinal OncologyMedicinePharmacologyAdvanced Pancreatic CancerCancer TreatmentVersus CapecitabineOncologyRadiation OncologyCancer ResearchFinal Results